GLP-1 and Multiple Sclerosis: What UK Patients Should Know (October 2026)

01 · The short answer

Can you take a GLP-1 medicine if you have MS?

Possibly, but it is a decision for a prescriber who knows your full history, not something a web page can settle. Mounjaro is licensed for adults with a BMI of 30 or above, or 27 to 30 with a weight-related condition, alongside a reduced-calorie diet and more physical activity.¹ MS is not a listed qualifying condition and not a licensed reason to take it.

A prescriber will assess your BMI, medical history and current medicines before deciding whether it is suitable.¹ For someone with MS, that means telling us about your disease-modifying treatment, any symptom treatments, and how your MS currently affects you. Our guides on Mounjaro and multiple sclerosis and whether you can take Mounjaro with MS go into the Mounjaro-specific questions.

02 · Honest limits

Research and MS

Mounjaro's licensed uses are weight management and type 2 diabetes, and its trials were in obesity, so they do not show how it affects MS.

Do not start a weight-loss injection hoping it will act as an MS treatment. Keep taking the treatment your neurologist prescribed.

03 · Cost and ordering

What it costs and how ordering works

If a prescriber approves treatment, your first 2.5mg pen costs £129.99 with code FIRST40 (standard price £169.99). Every later order is £25 off the standard price, applied automatically (code DOSE25). If you step up after 4 weeks on each dose, your first four pens (2.5mg to 10mg) cost £959.96 at standard prices, before those discounts. All six doses are in stock. You can see the full range on our weight loss treatments page.

Ordering works in three steps:

• Complete the free online consultation. It is a short health questionnaire with no charge and no obligation. Include your MS diagnosis and medicines.
• A GPhC-registered prescriber reviews it. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.
• Our registered pharmacy dispenses and dispatches. Same-day dispatch applies when ordered by 3pm, with free next-day tracked delivery in discreet, temperature-controlled packaging.

Related guides: Mounjaro Before and After 1 Month and mounjaro with multiple sclerosis and Glp1 and multiple myeloma.

04 · How GLP-1 works

How GLP-1 and GIP/GLP-1 medicines work

Tirzepatide activates two natural gut-hormone receptors at once, GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹ In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.

That is the licensed mechanism, and it relates to appetite and blood sugar. It says nothing about the nervous system or MS.

In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages and individual results vary. The trial does not tell us how people with MS respond, so do not read it as a prediction for you.

05 · Weight and MS

Weight management when you live with MS

Wanting to manage weight with MS is reasonable, and the practical route starts with your care team. Fatigue, mobility changes and some medicines can make diet and activity harder, so a plan needs to fit your situation. Mounjaro must be used alongside a reduced-calorie diet and increased physical activity, not instead of them.¹ If you have severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis), get medical help straight away. Pain in the upper right abdomen, fever or yellowing of the skin or eyes (possible gallbladder problems), or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing, also need immediate medical help.

Questions worth raising with your neurologist, MS nurse or GP before applying:

• Is now a stable point in my MS to make a change to my treatment?
• Could a weight-loss medicine interact with anything I already take?
• What activity is realistic for me, and who can support me with it?
• How will we tell if a new symptom is MS-related or medicine-related?

The last point matters. New symptoms should be discussed with your prescriber, and you can report suspected side effects through the Yellow Card scheme.¹⁹ Our wider guide to weight loss drugs and multiple sclerosis covers the other options.

06 · Safety and medicines

Medicines, interactions and safety

Which medicines matter with MS depends on your diagnosis and treatment, and the person best placed to say is your neurologist or pharmacist. Our prescriber reviews everything you tell us against Mounjaro's product information.¹³

That review is why accuracy on the consultation form matters. List every prescription, over-the-counter product and supplement. Repeat orders re-check suitability, and there is no auto-shipping, so a change in your MS treatment can be picked up at the next review.

Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4 to 5 weeks to clear the system.¹ If you and your neurologist decide it is not right for you, nothing needs doing while it clears, but speak to your prescriber.

07 · Other GLP-1 options

Other GLP-1 medicines and what people ask next

Mounjaro is a once-weekly injection that acts on GIP and GLP-1, which distinguishes it from single-action GLP-1 medicines such as semaglutide.¹ If you are weighing options, our Wegovy pen page explains the semaglutide route. The same MS caveat applies: neither is licensed to treat MS.

08 · NHS access

NHS access to Mounjaro

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition.⁴ The primary-care rollout began in June 2025 with the highest-need groups first, initially BMI 40+ with four or more qualifying conditions.⁶

Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting. Ask your GP or MS team where you stand locally. Private treatment through us includes ongoing monthly reviews and side-effect support from the prescribing team, and our pharmacy is GPhC-registered (9012878).